Internal Server Error

Mesh Bio - About the company

Mesh Bio is a series A company based in Singapore (Singapore), founded in 2018 by Melvin Heng, Arsen Batagov and Andrew Wu. It operates as a Provider of chronic disease management software. Mesh Bio has raised $6.5M in funding from investors like East Ventures, Enterprise Singapore and Elev8. The company has 274 active competitors, including 70 funded and 19 that have exited. Its top competitors include companies like Verily, Wellframe and Closedloop Medicine.

Company Details

Mesh Bio provides software for chronic disease management through predictive analytics. The software translates clinical data and numbers into actionable insights that help patients better manage their health, lifestyle, and disease risks. The software provides clinical decision support for healthcare professionals
Email ID
*****@meshbio.com
Key Metrics
Founded Year
2018
Location
Singapore, Singapore
Stage
Series A
Total Funding
$6.5M in 2 rounds
Latest Funding Round
Ranked
Annual Revenue
362K SGD as on Dec 31, 2022
Employee Count
27 as on May 31, 2026
Similar Companies
Sign up to download Mesh Bio's company profile

Mesh Bio's funding and investors

Mesh Bio has raised a total funding of $6.5M over 2 rounds. Its first funding round was on Mar 10, 2021. Its latest funding round was a Series A round on Oct 12, 2023 for $*****. 3 investors participated in its latest round. Mesh Bio has 10 institutional investors and 8 angel investors.

Here is the list of recent funding rounds of Mesh Bio:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 12, 2023
7827064
Series A
3060757
9071603
6309403
1323090
Mar 10, 2021
6613986
Seed
2123308
1715187
lockAccess funding benchmarks and valuations. Sign up today!

Mesh Bio's founders and board of directors

Founder? Claim Profile
The founders of Mesh Bio are Melvin Heng, Arsen Batagov and Andrew Wu. Andrew Wu is the CEO of Mesh Bio.
Here are the details of Mesh Bio's key team members:

Mesh Bio's Board of Directors

Mesh Bio's board has 6 active members. Arsen Batagov and Andrew Wu are part of team and Willson Cuaca, Aditya Mathur, Anastasia Ling Yew Lin and Reuben Lai Yuen Tung are independent board members.
Here is the list of Mesh Bio's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
7y 3m
Team
-
Current
7y 11m
ncoijwb
Team
-
Past
9y 7m
Independent board member
-
Current
1y 11m
yhatcqz
Independent board member
-
Current
4y 4m
dfnjvzt
Independent board member
-
Current
5y 3m
ediissm
Independent board member
-
Past
4y 4m
syjj{tr
Independent board member
-
Past
5y 5m

Mesh Bio's employee count trend

Mesh Bio has 27 employees as of May 26. Here is Mesh Bio's employee count trend over the years:
Employee count trend for Mesh Bio
lockUncover Mesh Bio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Mesh Bio's Competitors and alternates

Top competitors of Mesh Bio include Verily, Wellframe and Closedloop Medicine. Here is the list of Top 10 competitors of Mesh Bio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Verily
Verily
2015, Dallas (United States), Series D
Developer of precision health platforms and solutions using artificial intelligence
$2.8B
79/100
2nd
Logo for Wellframe
Wellframe
2011, Boston (United States), Acquired
Mobile and AI-based platform offering support to providers for better patient engagement
$45.1M
67/100
3rd
Logo for Closedloop Medicine
Closedloop Medicine
2017, Cambridge (United Kingdom), Series A
Developer of personalized medicine platforms combining drug therapy and digital care
$30M
66/100
4th
Logo for Rimidi Diabetes
Rimidi Diabetes
2012, Coral Gables (United States), Acquired
Cloud-based platform for diabetes management
$12.8M
64/100
5th
Logo for Memora Health
Memora Health
2015, Boston (United States), Acquired
Mobile platform for chronic disease management
$80.6M
63/100
6th
Logo for VitalTech
VitalTech
2002, Plano (United States), Acquired
Provider of a cloud-based platform for monitoring patient and employee health
$26.3M
62/100
7th
Logo for Brook
Brook
2015, Series A
Provider of remote patient care blending clinical teams with artificial intelligence
$32M
61/100
8th
Logo for Glytec
Glytec
2005, United States, Series C
Cloud based platform for diabetes and insulin management
$56.3M
57/100
9th
Logo for TimeDoc
TimeDoc
2015, Chicago (United States), Series B
Provider of the chronic care management solution for healthcare professionals
$56.7M
56/100
10th
Logo for ThoroughCare
ThoroughCare
2013, Spartanburg (United States), Series A
Care coordination software and clinical guidance to optimize patient care management
$11M
55/100
16th
Logo for Mesh Bio
Mesh Bio
2018, Singapore (Singapore), Series A
Provider of chronic disease management software
$6.5M
50/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Mesh Bio's competitors? Click here to see the top ones

Mesh Bio's Investments and acquisitions

Mesh Bio has made no investments or acquisitions yet.

Reports related to Mesh Bio

Here is the latest report on Mesh Bio's sector:

News related to Mesh Bio

lockFilter this list
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Mesh Bio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford